APA (7th ed.) Citation

Corona SP & Generali D. (2018). Abemaciclib: A CDK4/6 inhibitor for the treatment of HR+/HER2– advanced breast cancer. Dove Medical Press.

Chicago Style (17th ed.) Citation

Corona SP and Generali D. Abemaciclib: A CDK4/6 Inhibitor for the Treatment of HR+/HER2– Advanced Breast Cancer. Dove Medical Press, 2018.

MLA (9th ed.) Citation

Corona SP and Generali D. Abemaciclib: A CDK4/6 Inhibitor for the Treatment of HR+/HER2– Advanced Breast Cancer. Dove Medical Press, 2018.

Warning: These citations may not always be 100% accurate.